Tower Research Capital LLC (TRC) - MOLECULIN BIOTECH INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q3 2023$6,123
-26.4%
14,305
-0.5%
0.00%
Q2 2023$8,323
+69258.3%
14,374
+16.6%
0.00%
Q1 2023$12
+100.0%
12,329
+130.2%
0.00%
Q4 2022$6
-99.9%
5,355
-45.2%
0.00%
Q3 2022$10,000
+66.7%
9,772
+133.8%
0.00%
Q2 2022$6,000
-14.3%
4,180
-0.3%
0.00%
Q1 2022$7,0004,191
+10377.5%
0.00%
Q3 2021$0
-100.0%
40
-98.4%
0.00%
Q2 2021$9,0002,5130.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q4 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,004,845$3,688,0000.92%
XTX Topco Ltd 32,997$121,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 29,188$107,0000.02%
GSA CAPITAL PARTNERS LLP 31,120$114,0000.01%
Virtu Financial LLC 25,302$93,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 31,200$115,0000.00%
CVA Family Office, LLC 500$2,0000.00%
RAYMOND JAMES & ASSOCIATES 14,986$55,0000.00%
UBS Group AG 1,071$4,0000.00%
OSAIC HOLDINGS, INC. 801$3,0000.00%
View complete list of MOLECULIN BIOTECH INC shareholders